HR - Healthcare Realty Trust Incorporated
NYSE
->
Real Estate
->
REIT—Healthcare Facilities
Nashville,
United States
Type: Equity
HR price evolution
HR
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $41.77 | $26.17 | $25.7 | $24.67 |
| Short term investments | ||||
| Net receivables | $180.07 | |||
| Inventory | ||||
| Total current assets | $205.77 | $24.67 | ||
| Long term investments | ||||
| Property, plant & equipment | $10696.67 | $11308.98 | $11448.19 | $11873.89 |
| Goodwill & intangible assets | $250.53 | $250.53 | ||
| Total noncurrent assets | ||||
| Total investments | $374.84 | $309.75 | $311.51 | $325.45 |
| Total assets | $11803.63 | $12280.92 | $12637.13 | $13103.73 |
| Current liabilities | ||||
| Accounts payable | $195.88 | $163.17 | $211.99 | $204.95 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $441.71 | $478.27 | ||
| Long term debt | $5069.36 | $5301.5 | ||
| Total noncurrent liabilities | ||||
| Total debt | $5453.95 | $5412.27 | $5299.08 | $5574.82 |
| Total liabilities | $5828.94 | $5773.91 | $5714.35 | $5994.94 |
| Shareholders' equity | ||||
| Retained earnings | -$3463.51 | -$3202.24 | -$2773 | -$2614.82 |
| Other shareholder equity | $6.99 | $4.79 | -$10.74 | $17.08 |
| Total shareholder equity | $5887.14 | $6415.9 | $6822.66 | $7003.7 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $25.7 | $60.96 | $57.07 | $118.77 |
| Short term investments | ||||
| Net receivables | $180.07 | $143.53 | $334.94 | $251.73 |
| Inventory | ||||
| Total current assets | $205.77 | $204.5 | $249.83 | $143.4 |
| Long term investments | ||||
| Property, plant & equipment | $11448.19 | $12749.34 | $6397.06 | $6345.39 |
| Goodwill & intangible assets | $250.53 | $223.2 | $10.72 | $10.45 |
| Total noncurrent assets | ||||
| Total investments | $311.51 | $327.25 | $62.83 | $64.36 |
| Total assets | $12637.13 | $13849.63 | $6889.69 | $6790.69 |
| Current liabilities | ||||
| Accounts payable | $211.99 | $57.35 | $198.08 | $200.36 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $441.71 | $552.45 | $480.59 | $175.7 |
| Long term debt | $5069.36 | $5424.77 | $3028.12 | $1619.4 |
| Total noncurrent liabilities | ||||
| Total debt | $5299.08 | $5704.66 | $3224.41 | $3225.37 |
| Total liabilities | $5714.35 | $6278.56 | $3545.37 | $3555.77 |
| Shareholders' equity | ||||
| Retained earnings | -$2773 | -$2022.51 | -$1915.78 | -$1727.75 |
| Other shareholder equity | -$10.74 | $2.14 | -$7.04 | -$16.98 |
| Total shareholder equity | $6822.66 | $7571.08 | $3257.6 | $3174.24 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $316.32 | $326.81 | $330.44 | |
| Cost of revenue | $117.72 | $121.08 | $121.36 | |
| Gross Profit | $198.6 | $205.73 | $209.08 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $14 | $14.79 | $14.61 | |
| Total operating expenses | $187.91 | $193.3 | $196.37 | |
| Operating income | $10.69 | $12.43 | $12.71 | |
| Income from continuing operations | ||||
| EBIT | -$81.57 | -$249.78 | $22.65 | |
| Income tax expense | ||||
| Interest expense | $62.21 | $61.05 | $63.19 | |
| Net income | ||||
| Net income | -$143.78 | -$310.84 | -$40.53 | |
| Income (for common shares) | -$143.78 | -$310.84 | -$40.53 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1343.77 | $932.64 | $767.07 | $738.97 |
| Cost of revenue | $500.44 | $344.04 | $236.85 | $226.86 |
| Gross Profit | $843.33 | $588.6 | $530.22 | $512.11 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $58.41 | $52.73 | $49.74 | $42.97 |
| Total operating expenses | $789.19 | $612.42 | $376.89 | $347.76 |
| Operating income | $54.14 | -$23.83 | $153.34 | $164.34 |
| Income from continuing operations | ||||
| EBIT | -$19.68 | $189.13 | $190.78 | $147.23 |
| Income tax expense | ||||
| Interest expense | $258.58 | $148.24 | $92.76 | $94.61 |
| Net income | ||||
| Net income | -$278.26 | $40.9 | $98.02 | $52.62 |
| Income (for common shares) | -$278.26 | $40.9 | $98.02 | $52.62 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | -$143.78 | -$310.84 | -$40.53 | -$67.84 |
| Operating activities | ||||
| Depreciation | $186.1 | $190.88 | $192.89 | $194.94 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $3.38 | $3.56 | $2.82 | $2.55 |
| Total cash flows from operations | $168.15 | $76.15 | $127.32 | $118.18 |
| Investing activities | ||||
| Capital expenditures | $212.34 | -$58.55 | $249.69 | $120.52 |
| Investments | -$2.4 | -$0.02 | -$13.02 | -$1.91 |
| Total cash flows from investing | $209.95 | -$58.56 | $236.68 | $118.61 |
| Financing activities | ||||
| Dividends paid | -$117.35 | -$118.27 | -$118.07 | -$118.07 |
| Sale and purchase of stock | -$273.06 | -$0.21 | -$0.44 | $0.04 |
| Net borrowings | $29.66 | $102.56 | -$243.16 | -$128.62 |
| Total cash flows from financing | -$362.51 | -$17.12 | -$362.96 | -$248.03 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $15.59 | $0.47 | $1.03 | -$11.24 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$278.26 | $40.9 | $98.02 | $52.62 |
| Operating activities | ||||
| Depreciation | $781.97 | $481.15 | $283.3 | $283.04 |
| Business acquisitions & disposals | -$3.82 | $1059.87 | ||
| Stock-based compensation | $14.29 | $20.35 | $7.26 | $8.92 |
| Total cash flows from operations | $499.82 | $272.75 | $385.62 | $387.96 |
| Investing activities | ||||
| Capital expenditures | $380.18 | $597.13 | -$414.67 | -$337.11 |
| Investments | -$27.21 | -$22.64 | -$72.81 | -$5.09 |
| Total cash flows from investing | $349.14 | $1634.36 | -$399.86 | -$319.26 |
| Financing activities | ||||
| Dividends paid | -$472.24 | -$1407.36 | -$281.82 | -$275.82 |
| Sale and purchase of stock | -$2.17 | $19.71 | $247.84 | $46.21 |
| Net borrowings | -$404.16 | -$457.23 | $253.57 | |
| Total cash flows from financing | -$884.22 | -$1859.33 | -$47.46 | $12.45 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$35.26 | $47.79 | -$61.7 | $81.15 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.84 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |